PRGS&Tech has embarked on strengthening its global intellectual property (IP) competitiveness.


PRGS&Tech Selected as "Global IP Star Company" View original image

On the 27th, PRGS&Tech announced that it has been finally selected for the "2026 Global IP Star Company Fostering Project" operated by the Busan Intellectual Property Center. The Global IP Star Company Fostering Project is a program that provides comprehensive support related to intellectual property rights for up to three years to promising small and medium-sized enterprises (SMEs) with high potential for overseas expansion. Its core purpose is to discover companies with technological competitiveness and global growth potential and support their entry into the global market.


PRGS&Tech explained that through this selection, it has established an opportunity to strengthen its rare disease drug development capabilities and global commercialization foundation. The company plans to continue pursuing a global expansion strategy centered on its core pipeline and further enhance its IP competitiveness.


PRGS&Tech is an R&D-focused company specializing in the development of rare disease treatments, possessing protein-protein interaction (PPI) inhibition technology and candidate optimization technology based on the pathogenesis of genetic diseases. The company is currently building an IP portfolio in major global markets based on key technologies such as candidate substances for each new drug pipeline and core synthetic process technologies grounded in disease mechanisms. PRGS&Tech is conducting new drug development targeting conditions such as Hutchinson-Gilford Progeria Syndrome (HGPS), Type 2 Neurofibromatosis (NF2), and Amyotrophic Lateral Sclerosis (ALS).



A company official stated, "Being selected as a Global IP Star Company is a meaningful achievement that recognizes our rare disease treatment technology and the competitiveness of our global IP strategy," adding, "Going forward, we plan to strengthen the protection of core pipeline rights and accelerate the expansion of global commercialization and strategic partnerships."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing